<DOC>
	<DOCNO>NCT01005719</DOCNO>
	<brief_summary>This study determine difference Proton Pump Inhibitors ( PPI ) formulation relative effect gastric acidity .</brief_summary>
	<brief_title>Study Compare Gastric Inhibition Two Proton Pump Inhibitors ( CL2008-18 ) ( P07815 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole , sodium bicarbonate drug combination</mesh_term>
	<criteria>Healthy nonAsian , male nonlactating , nonpregnant female participant 1865 year age . Clinical laboratory test must within normal limit clinically acceptable Investigator/Sponsor . Participants must normal clinically acceptable physical exam ECG . Participants must free clinically significant disease require physician 's care and/or would interfere study evaluation , procedure , participation . Able understand comply study procedure require able willing provide write informed consent prior study procedure perform . History hypersensitivity , allergy intolerance omeprazole , proton pump inhibitor History peptic ulcer disease acid related gastrointestinal symptom heartburn frequency one/month . Positive H. pylorus breath test screening . Participation study investigational treatment 30 day Screening participation another study time period study Any significant medical illness would contraindicate participation study Gastrointestinal disorder surgery lead impaired drug absorption Any significant mental illness , schizophrenia bipolar disorder History ( past year ) suggestive alcohol drug abuse dependence , excessive alcohol use ( &gt; 2 unit per day average ; example &gt; 2 bottle beer , &gt; 2 glass wine , &gt; 2 ounce liquor/spirits ) , excessive alcohol use study Any abnormal Screening laboratory value clinically significant investigator 's opinion Currently use use prescription counter ( OTC ) medication affect gastrointestinal function , include first generation antihistamine ( e.g . diphenhydramine ) anticholinergic agent within 7 day prior 1st treatment administration . Currently use , use within 14 day first treatment administration , history frequent use antacid , OTC Prescription ( Rx ) H2 receptor antagonist , OTC Rx use proton pump inhibitor . Positive urine drug/alcohol test Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>